At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
Mostrar 4 de 8
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
An indispensable part of the ConsiGma portfolio, the Conductor control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.
Con el GEA kytero 10, los investigadores y desarrolladores de las industrias biofarmacéutica, alimentaria y de nuevos alimentos tienen ahora a su disposición un potente acelerador de generación avanzada.
Desde el ahorro de costes hasta la reducción de emisiones, GEA lidera proyectos innovadores de tecnología de bombas de calor. Explore las iniciativas de calefacción tradicional y central.
GEA ayuda a sus clientes a probar y escalar ovoproductos e ingredientes alternativos elaborados con fermentación de precisión.